




























































Rice-derived glucosylceramides up-regulate HLA-DR expression on myeloid dendritic cells to activate innate immune responses in healthy Japanese subjects: A randomized, placebo-controlled, double-blind trial
							| Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007



	

				
						
 
	Skip to main content
	Skip to main navigation menu
		Skip to site footer


			

				
					
						Open Menu
					
										
																Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007
										

				


				
				
					
					
						
																					
				
					Home
				
										
									
										Food Science Publisher
									
								
	
									
										Functional Food Center
									
								


							
	
				
					Current
				
							
	
				
					Archives
				
							
	
				
					About
				
										
									
										About the Journal
									
								
	
									
										Aims and Scope
									
								
	
									
										Contact
									
								
	
									
										Editing Services
									
								
	
									
										Editorial Team
									
								
	
									
										Express Peer Review
									
								
	
									
										Graphical Abstract
									
								
	
									
										Journal Insights
									
								
	
									
										Privacy Statement
									
								
	
									
										Submissions
									
								


							
	
				
					Announcements
				
							
	
				
					Search
				
							



				

																						
									
										
										Search
									
								

													

					

					
								
				
					Register
				
							
	
				
					Login
				
							



					

				
			

		

						
			
				


			
		
			
				Home
			
			/
		
	
			
				Archives
			
			/
		
	
				
					Vol. 15 No. 8 (2025): August 2025
				
				/
			
	
			
									Research Articles
							
		



	
		  	 

		
	
		Rice-derived glucosylceramides up-regulate HLA-DR expression on myeloid dendritic cells to activate innate immune responses in healthy Japanese subjects: A randomized, placebo-controlled, double-blind trial
	


	
	
		

							
					Authors

						
							
								Kenchi Miyasaka
							
																																		
	
							
								Shogo Takeda
							
																																		
	
							
								Akari Yoneda
							
																																		
	
							
								Mizuki Kubo
							
																																		
	
							
								Hiroshi Shimoda
							
																																		


				
			
																	
					
												DOI:
					

					
						
							https://doi.org/10.31989/ffhd.v15i8.1666
						
					
				
			

						
										
					Abstract

					Introduction: In a prior study, we found that rice-derived glucosylceramides (GlCer) improved overall health and alleviated common cold symptoms, including nasal congestion, sore throat, coughing, headache, muscle pain, and diarrhea. One of the underlying mechanisms may involve the enhanced activation of antigen-presenting cells (APC) through Mincle, a c-type lectin receptor, and toll-like receptors. However, the clinical impact of GlCer on cell-mediated innate immunity, especially concerning APC, is not yet fully understood. 

Objective: Therefore, we performed a clinical study on the effects of commercially available rice-GlCer (Oryza Ceramide®) on blood dendritic cells (DC).

Methods: The study was planned as a randomized, placebo-controlled, double-blind trial. Oryza Ceramide®-PCD (OC-PCD, 20 mg) tablets, each containing 0.6 mg of GlCer, were used as the active tablet. Twenty-two healthy Japanese individuals were enrolled and randomly divided to an active group (n=11) or placebo group (n=11 For 8 weeks, participants took three active tablets (60 mg of OC-PCD) or three placebo tablets daily. DC ratios and CD expression on DC during the intervention were set as the primary outcomes. 

Results: All subjects finished the trial, and the per protocol set constituted 11 in each group. The myeloid DC (mDC) ratio and CD86 expression were significantly lower in the active group than in the placebo group. In contrast, HLA-DR expression on mDC was slightly higher in the active group. A stratified analysis of subjects with mean fluorescence intensity (MFI) for HLA-DR <60,000 revealed a significant high value in HLA-DR expression in the active group. A correlation was observed between changes in MFI values for HLA-DR and CD86 on mDC. However, plasmacytoid DC parameters did not change. 

Novelty of the Study: Rice-derived GlCer was firstly clarified to enhance innate immune response specifically mDC to improve common cold symptoms through this clinical trial.

Conclusions: The oral administration of GlCer affected mDC by up-regulating the expression of HLA-DR and down-regulating CD86, which contribute to antigen presentation to T lymphocytes. The present results suggests that GlCer attenuate cold symptoms by enhancing the interaction between mDC and T lymphocytes.

Trial Registration: UMIN-CTR: UMIN000055299

Keywords: rice; glucosylceramide; HLA-DR; dendritic cells; CD86

				
			
			

						
																																															
						
		


		

						
										
					
						Downloads
					

						
								
	
													


		
	[Abstract]

	
							
	
								
	
													


		
	[Full Article]

	
							


				

						
						
				
					
						Published
					

					
																			2025-08-04
																	

				
							

			
						
										

											
							
								Issue
							

							
								
									Vol. 15 No. 8 (2025): August 2025
								
							

						
					
											
							
								Section
							

							
								Research Articles
							

						
					
									

			
						
										
					
						License
					

																										Copyright (c) 2025 Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007

														This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

																Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.

				

			
			

		

	




	




	


							



	

	

					
				About the Journal      Editing Services      Graphical Abstract      Journal Insights        Submissions        Editorial Team       Privacy Statement        Contact        Current        Archives

 

			

		
		Open Journal Systems Hosting and Support by: OpenJournalSystems.com


	










